Get the latest clinical and surgical news about the Nucleus® Systems, cochlear implant candidacy, reliability, hearing loss and more. Check it out!
In March 2020 the FDA approved the first expansion of pediatric indications in 20 years. Dr. Jace Wolfe, Director of Audiology and Research at the Hearts for Hearing Foundation in […]
By Patti Trautwein, MA, AuD, Vice President, Marketing at Cochlear Americas Jacques Herzog, MD of Washington University School of Medicine in St. Louis, answers questions about resuming implant surgeries and […]
By Duncan Meldrum, Senior Manager of Professional Engagement at Cochlear Development of a 60/60 Guideline for Referring Adults for a Traditional Cochlear Implant Candidacy Evaluation Zwolan, Teresa A.; Schvartz-Leyzac, Kara […]
By Ryan Lopez, Director, Nucleus® Product Management & Marketing at Cochlear Americas Quality products start with Cochlear’s commitment to putting recipients first and expanding access to information to reinforce transparency. […]
By Wade Colburn, Product Manager – Cochlear Implants Early in the COVID-19 crisis, widespread uncertainty led to clinic visits and surgeries being postponed or cancelled until further notice. While the […]
Dr. Jace Wolfe, clinical audiologist and Director of Audiology and Research at the Hearts for Hearing Foundation in Oklahoma City, uses his 22 years of cochlear implant experience to examine […]
By Kyle Longwell, Product Manager – Software and Clinical Care at Cochlear Recent studies1,2 support the notion that patient outcomes don’t only include a speech score – the incorporation of […]
In today’s busy clinical environment, clinicians who value research-based practice often struggle to keep up with current literature. Our monthly Journal Club feature includes rotating guest authors who present current […]
By Rebecca Cale, Regional Clinical Training Manager at Cochlear Americas Cristofari, E., Cuda, D., Martini, A., Forli, F., Zanetti, D., Di Lisi, D., Marsella, P., Marchioni, D., Vincenti, V., Aimoni, […]
Amid COVID-19 pandemic, remote healthcare solutions are a priority now more than ever Centennial, Colo. (April 7, 2020) — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained […]
End of content
No more pages to load
